Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nijmegen Breakage Syndrome
|
17 | 0.701 | 0.280 | 8 | 89971232 | missense variant | G/A;C | snv | 2.5E-03 | 0.740 | 1.000 | 4 | 2006 | 2012 | |||||
Malignant Neoplasms
|
1441 | 0.701 | 0.280 | 8 | 89971232 | missense variant | G/A;C | snv | 2.5E-03 | 0.040 | 1.000 | 4 | 2004 | 2013 | |||||
Breast Carcinoma
|
2145 | 0.701 | 0.280 | 8 | 89971232 | missense variant | G/A;C | snv | 2.5E-03 | 0.030 | 1.000 | 3 | 2004 | 2014 | |||||
Malignant neoplasm of breast
|
2154 | 0.701 | 0.280 | 8 | 89971232 | missense variant | G/A;C | snv | 2.5E-03 | 0.030 | 1.000 | 3 | 2004 | 2014 | |||||
Childhood Acute Lymphoblastic Leukemia
|
259 | 0.701 | 0.280 | 8 | 89971232 | missense variant | G/A;C | snv | 2.5E-03 | 0.020 | 1.000 | 2 | 2001 | 2006 | |||||
Neoplasms
|
1571 | 0.701 | 0.280 | 8 | 89971232 | missense variant | G/A;C | snv | 2.5E-03 | 0.020 | 1.000 | 2 | 2006 | 2013 | |||||
Primary malignant neoplasm
|
1374 | 0.701 | 0.280 | 8 | 89971232 | missense variant | G/A;C | snv | 2.5E-03 | 0.020 | 1.000 | 2 | 2004 | 2013 | |||||
Acute lymphocytic leukemia
|
211 | 0.701 | 0.280 | 8 | 89971232 | missense variant | G/A;C | snv | 2.5E-03 | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||
Adult Acute Lymphocytic Leukemia
|
154 | 0.701 | 0.280 | 8 | 89971232 | missense variant | G/A;C | snv | 2.5E-03 | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||
Adult Non-Hodgkin Lymphoma
|
39 | 0.701 | 0.280 | 8 | 89971232 | missense variant | G/A;C | snv | 2.5E-03 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
Childhood Non-Hodgkin Lymphoma
|
39 | 0.701 | 0.280 | 8 | 89971232 | missense variant | G/A;C | snv | 2.5E-03 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
Colorectal Carcinoma
|
1186 | 0.701 | 0.280 | 8 | 89971232 | missense variant | G/A;C | snv | 2.5E-03 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
Developmental delay (disorder)
|
37 | 0.701 | 0.280 | 8 | 89971232 | missense variant | G/A;C | snv | 2.5E-03 | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||
Global developmental delay
|
51 | 0.701 | 0.280 | 8 | 89971232 | missense variant | G/A;C | snv | 2.5E-03 | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||
Lymphoma, Non-Hodgkin
|
193 | 0.701 | 0.280 | 8 | 89971232 | missense variant | G/A;C | snv | 2.5E-03 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
Lymphoma, Non-Hodgkin, Familial
|
46 | 0.701 | 0.280 | 8 | 89971232 | missense variant | G/A;C | snv | 2.5E-03 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.701 | 0.280 | 8 | 89971232 | missense variant | G/A;C | snv | 2.5E-03 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
Malignant neoplasm of prostate
|
861 | 0.701 | 0.280 | 8 | 89971232 | missense variant | G/A;C | snv | 2.5E-03 | 0.010 | 1 | 2006 | 2006 | ||||||
melanoma
|
352 | 0.701 | 0.280 | 8 | 89971232 | missense variant | G/A;C | snv | 2.5E-03 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
Prostate carcinoma
|
858 | 0.701 | 0.280 | 8 | 89971232 | missense variant | G/A;C | snv | 2.5E-03 | 0.010 | 1 | 2006 | 2006 |